RAVANI, Annalisa
 Distribuzione geografica
Continente #
NA - Nord America 1.320
EU - Europa 258
AS - Asia 170
OC - Oceania 3
SA - Sud America 2
Totale 1.753
Nazione #
US - Stati Uniti d'America 1.317
CN - Cina 110
IT - Italia 75
TR - Turchia 57
UA - Ucraina 45
DE - Germania 39
GB - Regno Unito 24
SE - Svezia 24
PL - Polonia 20
FI - Finlandia 15
FR - Francia 7
CA - Canada 3
NL - Olanda 3
AT - Austria 2
AU - Australia 2
BR - Brasile 2
CH - Svizzera 1
ES - Italia 1
JP - Giappone 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RO - Romania 1
RU - Federazione Russa 1
VN - Vietnam 1
Totale 1.753
Città #
Fairfield 195
Woodbridge 169
Ashburn 124
Ann Arbor 106
Houston 100
Chandler 97
Seattle 82
Wilmington 77
Jacksonville 69
Cambridge 67
Izmir 40
Beijing 34
Ferrara 32
Nanjing 22
Warsaw 20
Shanghai 18
Princeton 17
Boardman 14
Falls Church 13
Milan 9
Jiaxing 8
Nanchang 8
Auburn Hills 7
Des Moines 7
Norwalk 6
San Diego 6
Los Angeles 5
Mountain View 5
Cagliari 4
Changsha 4
Redwood City 4
Tianjin 4
Dearborn 3
Hebei 3
Orange 3
Shenyang 3
Addison 2
Bremen 2
Changchun 2
Columbus 2
Erlangen 2
Islington 2
London 2
New York 2
Tappahannock 2
Toronto 2
Vienna 2
Washington 2
Zhengzhou 2
Auckland 1
Dong Ket 1
Frankfurt am Main 1
Grottammare 1
Hounslow 1
Indiana 1
Istanbul 1
Kilburn 1
Kunming 1
Lanzhou 1
Manila 1
Markham 1
Munich 1
New Bedfont 1
Padova 1
Redmond 1
Tokyo 1
Zurich 1
Totale 1.429
Nome #
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 149
Neurotensin NTS1-dopamine D2 receptor-receptor interactions in putative receptor heteromers: relevance for Parkinson's disease and schizophrenia. 143
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 140
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 131
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 123
Repeated dosing with NCX1404, a nitric oxide-donating pregabalin, re-establishes normal nociceptive responses in mice with streptozotocin-induced painful diabetic neuropathy 119
Design, Synthesis, and Pharmacological Characterization of 2-(2-Furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A2A Adenosine Receptor Inverse Agonists with Antinociceptive Activity 119
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 114
Dopamine D2 receptor signaling dynamics of dopamine D2-neurotensin 1 receptor heteromers. 108
The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles 100
Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields 96
null 91
null 83
Structural refinement of pyrazolo[4,3-d]pyrimidine derivatives to obtain highly potent and selective antagonists for the human A3 adenosine receptor 79
Effects of pulsed electromagnetic fields and platelet rich plasma in preventing osteoclastogenesis in an in vitro model of osteolysis 74
RAW 264.7 co-cultured with ultra-high molecular weight polyethylene particles spontaneously differentiate into osteoclasts: an in vitro model of periprosthetic osteolysis 72
A2A adenosine receptor upregulation correlates with disease activity in patients with systemic lupus erythematosus 27
Exploring the 7-oxo-thiazolo[5,4-d]pyrimidine core for the design of new human adenosine A3 receptor antagonists. Synthesis, molecular modeling studies and pharmacological evaluation 20
Pharmacological characterization of adenosine receptors in chronic inflammatory rheumatic diseases 17
Totale 1.805
Categoria #
all - tutte 6.813
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.813


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019157 0 0 0 0 0 0 0 0 0 0 61 96
2019/2020420 53 15 15 65 34 46 53 32 41 33 21 12
2020/2021355 17 12 8 32 51 22 8 48 24 78 40 15
2021/2022171 5 13 7 12 7 18 16 7 16 20 16 34
2022/2023223 20 18 13 24 33 26 17 19 33 0 11 9
2023/2024117 21 8 4 3 7 15 8 40 2 4 5 0
Totale 1.805